An Unbiased View of mouse
Experimentally, navitoclax kills cells within a BAX/BAK-dependent way and leads to regression of lymphoid tumors in xenograft models.On September 19, 2018, an article was released in Character about using this drug to destroy senescent glial cells in mice. The drug experienced a protecting influence from memory loss in mice genetically engineered t